학술논문
JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
13652141